Health Condition 1: M966- Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate
Conditions
Interventions
Intervention1: Supraclavicular Brachial Plexus Block versus Infraclavicular Brachial Plexus Block: 25 ml of 0.5% Bupivacaine drug used
Control Intervention1: NIL: NIL
Sponsors
Dr. Tanya Chawla
Eligibility
Inclusion criteria
Inclusion criteria: weighing 60 to 90kgs belonging to ASA I or II scheduled for elective upper limb surgery (elbow and/or below elbow)
Exclusion criteria
Exclusion criteria: Patient refusal known allergy to local anesthetics chronic pain BMI more than 35kgm2 heart, kidney or liver failure neurologival deficit in upper limb significant respiratory disorders serum creatinine more than 1.2 mg dl alcohol abuse coagulation disorders psychiatric disorders local infection pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the analgesic efficacy of supraclavicular brachial plexus block versus infraclavicular brachial plexus block in patients scheduled for elective upper limb surgery (elbow and/or below elbow) in terms of duration of analgesiaTimepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Block performace timeTimepoint: Baseline;time taken for onset of sensory & motor blockadeTimepoint: Baseline, 5 mins, 10 mins, 15mins, 20 mins, 25 mins, 30 mins;analgesic efficacy as assessed by Numeric Rating Scale scoreTimepoint: Immediate 1 hour 2 hours 4 hours 6 hours 12 hours 24 hours;requirement & total dose of additional rescue analgesic consumed during first 24 hours post operative periodTimepoint: Immediate 1 hour 2 hours 4 hours 6 hours 12 hours 24 hours | — |
Countries
India
Contacts
Public ContactDr Tanya Chawla
Fortis Hospital Noida
Outcome results
None listed